Navigation Links
Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
Date:11/5/2009

OMAHA, Neb., Nov. 5 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:

    What:     Transgenomic, Inc. Third Quarter 2009 Earnings Release
              Conference Call

    When:     Thursday, November 5, 2009 @ 5:00 p.m. Eastern

    Where:    http://www.transgenomic.com/events.asp?id=6

    How:      Live over the Internet -- Simply log on to the web at the
              address above.

    Contact:  Investor Relations, 402-452-5400

To access the call via telephone, call 800-862-9098 or 785-424-1051. A replay of the call will be available via telephone until 11:59 pm ET on Thursday, November 19, 2009. To access, dial 800-839-3613 or 402-220-2973.

About Transgenomic, Inc.

Transgenomic, Inc. (OTC BB: TBIO.OB, www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVE® Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, over 1,450 systems have been shipped to customers in more than 30 countries. The SURVEYOR®( )Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared to manual methods for cytogenetic analyses. Service offerings include the Tr
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
2. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
3. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
4. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
5. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) First Quarter 2008 Financial Results Call Set for May 6
6. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
7. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
11. Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...nd CHICAGO, Nov. 30 Today at the 9... Radiological Society of North America (RSNA), Ba...enrollment of the first patient in an internationa...y and safety of florbetaben (BAY 94-9172) PET imag...e brain, which are a pathological hallmark of Alzh...
(Date:11/30/2009)...IV, Israel, November 30 Optoacoust...) dual channel microphone, the most advanced,optic...etic resonance imaging,(fMRI) environments. ,... step forward for fiber,optic microphone technolog...h,low-latency adaptive noise cancelling. The FOMRI...
(Date:11/30/2009)...NAPOLIS, Nov. 30 The U.S...Cymbalta® (duloxetine HCl) for the maintenanc...in adults, Eli Lilly and Company (NYSE: LLY ) an...sorder can be a chronic illness, it is important t...tion that is effective in both the acute and maint...
Breaking Medicine Technology:Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5National Pasteurized Eggs Increases Access to Safe Pasteurized Shell Eggs With New Plant Opening During Septembers National Food Safety Education Mont 56107 1National Pasteurized Eggs Increases Access to Safe Pasteurized Shell Eggs With New Plant Opening During Septembers National Food Safety Education Mont 56107 2OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 13814 1OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 13814 2Physicians 26apos 3B Personalities Provide Clues Regarding Job Satisfaction 56098 1Physicians 26apos 3B Personalities Provide Clues Regarding Job Satisfaction 56098 2Physicians 26apos 3B Personalities Provide Clues Regarding Job Satisfaction 56098 3Physicians 26apos 3B Personalities Provide Clues Regarding Job Satisfaction 56098 4
...OD) today announced that its two pivotal Phase III...h the last study patient visit on July 14,2008. Re... Biodel,s poster,presentation at the European Asso...y, September 9, 2008, or at a later appropriate sc...bstracts containing interim data from,its VIAject(...
...2b Clinical Trials of First, Potential Therapy t..., SOUTH PLAINFIELD, N.J. and BETHESDA, Md., July ...is Foundation Therapeutics, Inc.,(CFFT), the nonpr...today,announced the expansion of an existing colla...,s new investigational oral drug for the treatment...
Other Medicine Technology:Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 2Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 3Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 4Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 5PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 2PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 3PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 4
(Date:11/30/2009)..., Peter J. Rappa, MD, exp...d the body in his new book "Healing Heart to ...g, and Life" (Brown Books 2009). , ...9 -- Experiencing and refusing to let go of negat... others, can weigh heavy on our shoulders. Oftenti...
(Date:11/30/2009)..., , ENGLEWOOD, Colo., Nov. 30 /PRNew...ional presentation discussing what "culture of saf...idday Symposium presentation, "Creating a Culture...th-system professionals discussing their experienc...a culture of safety in pharmacy and the role of te...
(Date:11/30/2009)..., , ROCKLAND, Mass., Nov. 30 /PRNewswir...stadt, Germany, announced today that it received a...dministration (FDA) on the New Drug Application (N...ry investigational oral formulation of cladribine,...rosis (MS). ,, "The company will work closely ...
(Date:11/30/2009)..., , MINNEAPOLIS, Nov. 30 ...age and Supplemental Medicare insurance customers ...switch their Medicare coverage. The figure is up ...intention to switch" measure has been a leading in...everyone with some intention to switch actually wi...
(Date:11/30/2009)... Improved screening, awareness may help delay prog... , MONDAY, Nov. 30 (HealthDay News) -- Medic...States costs $185.5 billion a year, according to a....4 billion while patients pay $36.1 billion in out...per female patient and $4,036 per male patient. Wo...
Breaking Medicine News(10 mins):Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3Health News:More Seniors Considering Health Insurance Switch 2Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2
... Weight Loss, Proper Nutrition, and Fitness n...25,000 Max Muscle MaxFormation Life Challenge Ener.../ . , Anaheim, CA (PRWEB)...t of the $25,000 MaxFormation Life Challenge as it...
... When Physicians for Human Rights (PHR) relea...abwe,s health system collapse the reported cholera...y exceeds 3,000, according to the World Health Org...diplomacy to strengthen respect for human rights. ...
... AllHealthcarejobs.com, an Internet based med...d healthcare job seekers 4-fold in both 2007 and a...chieved very strong growth in website traffic - be...HealthcareJobs.com, an internet medical job bank s...
...gold nanospheres equipped with a targeting peptide...hen cook the tumor when bathed with near-infrared ...iversity of Texas M. D. Anderson Cancer Center rep...gy for cancer. We,re getting closer to that goal,"...
... Research at The Total Health Center shows th...creasing muscle mass without a major decrease in f...ruary 1, 2009 -- Scientists at The Total Health an...the Total Heath Center have released the prelimina...
... A study in the Feb. 1 issue of the journal SLEEP...nges in the levels of specific cytokines that are ... suggest that inflammation may be the pathway link...cent increase in C-reactive protein (CRP) levels a...
Other Medicine News:Health News:Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge 2Health News:Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge 3Health News:Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge 4Health News:As Obama Urges Emergency Action on Zimbabwe, Health Crisis Worsens 2Health News:As Obama Urges Emergency Action on Zimbabwe, Health Crisis Worsens 3Health News:AllHealthcareJobs.com Achieves a 4-fold Growth for a Second Year in a Row 2Health News:AllHealthcareJobs.com Achieves a 4-fold Growth for a Second Year in a Row 3Health News:Targeted nanospheres find, penetrate, then fuel burning of melanoma 2Health News:Targeted nanospheres find, penetrate, then fuel burning of melanoma 3Health News:Study suggests that inflammation may be the link between extreme sleep durations and poor health 2
Cortex Extractor - Charleux
HydroExpression Cannula - Corydon
Hydrodissector - Pearce
Irrigating Cystotome
Medicine Products: